View in EDS HTML Full Text PDF Full Text

Immune recovery markers in a double blind clinical trial comparing dolutegravir and raltegravir based regimens as initial therapy (SPRING-2).

Saved in:
Bibliographic Details
Title: Immune recovery markers in a double blind clinical trial comparing dolutegravir and raltegravir based regimens as initial therapy (SPRING-2).
Authors: Blanco, Jose-Ramon1 (AUTHOR), Alejos, Belen2 (AUTHOR) balejos@isciii.es, Moreno, Santiago3 (AUTHOR)
Source: PLoS ONE. 1/16/2020, Vol. 15 Issue 1, p1-11. 11p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:19326203
DOI:10.1371/journal.pone.0226724